Trial intelligence / Profile preview

Envarsus vs Advagraf in de-novo kidney transplant

NCT02500212Phase 4Completed

Sponsor
Chiesi Farmaceutici S.p.A.
Start
Jul 2015
Primary completion
Jun 2016
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tacrolimus in kidney transplantation, sponsored by Chiesi Farmaceutici S.p.A.. Started Jul 2015; status: completed.

02

Drugs

tacrolimus
03

Conditions

kidney transplantation

Beyond the preview

Go deeper on NCT02500212.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02500212.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call